V011-0320 Screening compound: 2-{[4-(propan-2-yl)phenoxy]methyl}-N-{4-[4-(trifluoromethyl)benzamido]cyclohexyl}-1,3-thiazole-4-carboxamide

V011-0320 Screening compound: 2-{[4-(propan-2-yl)phenoxy]methyl}-N-{4-[4-(trifluoromethyl)benzamido]cyclohexyl}-1,3-thiazole-4-carboxamide
V011-0320 Screening compound: 2-{[4-(propan-2-yl)phenoxy]methyl}-N-{4-[4-(trifluoromethyl)benzamido]cyclohexyl}-1,3-thiazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V011-0320
2-{[4-(propan-2-yl)phenoxy]methyl}-N-{4-[4-(trifluoromethyl)benzamido]cyclohexyl}-1,3-thiazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V011-0320

Molecular Formula

C28H30F3N3O3S (C28 H30 F3 N3 O3 S)

Compound Name

2-{[4-(propan-2-yl)phenoxy]methyl}-N-{4-[4-(trifluoromethyl)benzamido]cyclohexyl}-1,3-thiazole-4-carboxamide

IUPAC name

2-{[4-(propan-2-yl)phenoxy]methyl}-N-{4-[4-(trifluoromethyl)benzamido]cyclohexyl}-13-thiazole-4-carboxamide

SMILES

CC(C)c(cc1)ccc1OCc1nc(C(NC(CC2)CCC2NC(c2ccc(C(F)(F)F)cc2)=O)=O)cs1

InChI

InChI=1S/C28H30F3N3O3S/c1-17(2)18-5-13-23(14-6-18)37-15-25-34-24(16-38-25)27(36)33-22-11-9-21(10-12-22)32-26(35)19-3-7-20(8-4-19)28(29,30)31/h3-8,13-14,16-17,21-22H,9-12,15H2,1-2H3,(H,32,35)(H,33,36)

InChI Key

LSCMVDCZYZCVKD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19968173

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

545.63

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.352

Distribution Coefficient, logD

6.352

Water Solubility, LogSw

-5.63

Polar Surface Area

66.052

Acid Dissociation Constant (pKa)

14.07

Base Dissociation Constant (pKb)

-0.66

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

39.30

V011-0320 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Lipid Metabolism Library (9174 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cardiovascular
  • Metabolic
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V011-0320 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V011-0320?
Check Price and Availability of V011-0320, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V011-0320 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V011-0320
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V011-0320
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V011-0320 available by request